Smith & Nephew Announces Vesting of Share Awards Under Global Plan

Smith & Nephew Snats ( (SNN) ) has provided an announcement.

On May 20, 2025, Smith & Nephew plc announced the vesting of share awards under its Global Share Plan 2020. The awards, which vested at 59.35% of the target, led to the sale of some shares to cover taxation obligations. This transaction, involving key executives like CEO Deepak Nath, signifies the company’s ongoing commitment to aligning management incentives with shareholder interests.

The most recent analyst rating on (SNN) stock is a Hold with a $27.27 price target. To see the full list of analyst forecasts on Smith & Nephew Snats stock, see the SNN Stock Forecast page.

Spark’s Take on SNN Stock

According to Spark, TipRanks’ AI Analyst, SNN is a Outperform.

Smith & Nephew Snats receives a solid overall score of 77.0, driven by strong financial performance and positive earnings call sentiment. The company’s impressive revenue and profit growth, coupled with innovation-driven strategies, contribute to a favorable outlook. However, high valuation ratios and technical analysis indicators suggest caution. Challenges in the China market and input cost pressures in Orthopedics remain key risks.

To see Spark’s full report on SNN stock, click here.

More about Smith & Nephew Snats

Smith & Nephew plc is a global medical technology company headquartered in Watford, England. The company specializes in advanced wound management, orthopaedics, and sports medicine, providing innovative solutions to improve patient outcomes.

Average Trading Volume: 888,350

Technical Sentiment Signal: Strong Buy

Current Market Cap: $12.75B

For a thorough assessment of SNN stock, go to TipRanks’ Stock Analysis page.